tradingkey.logo

LeonaBio Ord Shs

LONA
4.580USD
-0.210-4.38%
Close 02/06, 16:00ETQuotes delayed by 15 min
18.06MMarket Cap
LossP/E TTM

LeonaBio Ord Shs

4.580
-0.210-4.38%

More Details of Company

LeonaBio Ord Shs Info

Ticker Symbol- -
Company name- -
IPO date- -
CEO- -
Number of employees- -
Security type- -
Fiscal year-end- -
Address- -
City- -
Stock exchange- -
Country- -
Postal code- -
Phone- -
Website- -
Ticker Symbol- -
IPO date- -
CEO- -

Company Executives of LeonaBio Ord Shs

Name
Name/Position
Position
Shareholding
Change
Dr. Mark James Litton, Ph.D.
Dr. Mark James Litton, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
42.80K
-2586.00%
Dr. Kevin Church, Ph.D.
Dr. Kevin Church, Ph.D.
Chief Scientific Officer
Chief Scientific Officer
20.68K
-876.00%
Mr. Mark Worthington
Mr. Mark Worthington
Chief Compliance Officer, General Counsel, Company Secretary
Chief Compliance Officer, General Counsel, Company Secretary
13.98K
-876.00%
Mr. Robert Renninger
Mr. Robert Renninger
Senior Vice President - Finance, Accounting
Senior Vice President - Finance, Accounting
12.86K
-297.00%
Dr. Javier San Martin, M.D.
Dr. Javier San Martin, M.D.
Chief Medical Officer
Chief Medical Officer
10.19K
-1644.00%
Ms. Kelly A. Romano
Ms. Kelly A. Romano
Independent Chairwoman of the Board
Independent Chairwoman of the Board
8.07K
-2419.00%
Mr. Grant E. Pickering
Mr. Grant E. Pickering
Independent Director
Independent Director
2.58K
--
James A. Johnson ,
James A. Johnson ,
Independent Director
Independent Director
500.00
--
Ms. Barbara Kosacz, J.D.
Ms. Barbara Kosacz, J.D.
Independent Director
Independent Director
--
--
Mr. Joseph (Joe) Edelman
Mr. Joseph (Joe) Edelman
Independent Director
Independent Director
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Dr. Mark James Litton, Ph.D.
Dr. Mark James Litton, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
42.80K
-2586.00%
Dr. Kevin Church, Ph.D.
Dr. Kevin Church, Ph.D.
Chief Scientific Officer
Chief Scientific Officer
20.68K
-876.00%
Mr. Mark Worthington
Mr. Mark Worthington
Chief Compliance Officer, General Counsel, Company Secretary
Chief Compliance Officer, General Counsel, Company Secretary
13.98K
-876.00%
Mr. Robert Renninger
Mr. Robert Renninger
Senior Vice President - Finance, Accounting
Senior Vice President - Finance, Accounting
12.86K
-297.00%
Dr. Javier San Martin, M.D.
Dr. Javier San Martin, M.D.
Chief Medical Officer
Chief Medical Officer
10.19K
-1644.00%
Ms. Kelly A. Romano
Ms. Kelly A. Romano
Independent Chairwoman of the Board
Independent Chairwoman of the Board
8.07K
-2419.00%

Revenue Breakdown

Relevant data have not been disclosed by the company yet.
Relevant data have not been disclosed by the company yet.
By Business
By Region
Relevant data have not been disclosed by the company yet.

Shareholding Stats

Updated: Tue, Jan 13
Updated: Tue, Jan 13
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Perceptive Advisors LLC
47.14%
Acorn Capital Advisors, LLC
15.11%
Simplify Asset Management Inc
7.57%
Baselake Management, LLC
5.63%
Nemean Asset Management, LLC
4.09%
Other
20.45%
Shareholders
Shareholders
Proportion
Perceptive Advisors LLC
47.14%
Acorn Capital Advisors, LLC
15.11%
Simplify Asset Management Inc
7.57%
Baselake Management, LLC
5.63%
Nemean Asset Management, LLC
4.09%
Other
20.45%
Shareholder Types
Shareholders
Proportion
Private Equity
47.40%
Investment Advisor
28.70%
Corporation
9.73%
Individual Investor
4.14%
Hedge Fund
4.09%
Venture Capital
3.79%
Investment Advisor/Hedge Fund
2.15%
Family Office
0.98%
Research Firm
0.83%

Institutional Shareholding

Updated: Tue, Jan 13
Updated: Tue, Jan 13
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2026Q1
107
3.43M
86.99%
+588.35K
2025Q4
113
3.34M
84.62%
+1.00M
2025Q3
123
1.85M
47.14%
-805.95K
2025Q2
137
1.88M
48.34%
-780.64K
2025Q1
169
1.88M
48.36%
-912.05K
2024Q4
181
1.93M
49.87%
-1.07M
2024Q3
198
1.93M
50.33%
-1.16M
2024Q2
215
2.54M
66.42%
-582.38K
2024Q1
233
2.49M
65.12%
-1.23M
2023Q4
240
2.51M
65.92%
-1.08M
View more

Shareholder Activity

Name
Shares Held
Proportion
Change
Chg %
Date
Perceptive Advisors LLC
1.86M
47.14%
+1.32M
+244.13%
Dec 23, 2025
Acorn Capital Advisors, LLC
501.74K
12.72%
+501.74K
--
Dec 22, 2025
Simplify Asset Management Inc
298.56K
7.57%
--
--
Sep 30, 2025
Baselake Management, LLC
222.22K
5.63%
+222.22K
--
Nov 07, 2025
Nemean Asset Management, LLC
161.22K
4.09%
-38.25K
-19.17%
Oct 01, 2025
The Vanguard Group, Inc.
153.79K
3.9%
-2.00
-0.00%
Sep 30, 2025
Propel Bio Management, LLC
149.28K
3.79%
+149.28K
--
Dec 31, 2025
Tang Capital Management, LLC
60.00K
1.52%
-2.00
-0.00%
Sep 30, 2025
Renaissance Technologies LLC
51.92K
1.32%
+27.82K
+115.45%
Sep 30, 2025
Litton (Mark James)
45.38K
1.15%
+10.83K
+31.36%
Dec 31, 2025
View more

Related ETFs

Updated: Tue, Jan 13
Updated: Tue, Jan 13
Name
Proportion
Simplify Propel Opportunities ETF
1.54%
Dimensional US Core Equity 1 ETF
0%
iShares US Small-Cap Equity Factor ETF
0%
iShares Micro-Cap ETF
0%
DFA Dimensional US Sustainability Core 1 ETF
0%
iShares Neuroscience and Healthcare ETF
0%
Avantis US Small Cap Equity ETF
0%
Simplify Propel Opportunities ETF
Proportion1.54%
Dimensional US Core Equity 1 ETF
Proportion0%
iShares US Small-Cap Equity Factor ETF
Proportion0%
iShares Micro-Cap ETF
Proportion0%
DFA Dimensional US Sustainability Core 1 ETF
Proportion0%
iShares Neuroscience and Healthcare ETF
Proportion0%
Avantis US Small Cap Equity ETF
Proportion0%

Dividend

A total of 0.00 USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data

Stock Splits

Date
Ex-dividend Date
Type
Ratio
No Data
Date
Ex-dividend Date
Type
Ratio
No Data
KeyAI